UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
A Toll-like Receptor-Activating, Self-Adjuvant Glycan Nanocarrier Journal article
Daping Xie, Yiming Niu, Ruoyu Mu, Senio Campos de Souza, Xiaoyu Yin, Lei Dong, Chunming Wang. A Toll-like Receptor-Activating, Self-Adjuvant Glycan Nanocarrier[J]. Frontiers in Chemistry, 2022, 10.
Authors:  Daping Xie;  Yiming Niu;  Ruoyu Mu;  Senio Campos de Souza;  Xiaoyu Yin; et al.
Favorite | TC[WOS]:5 TC[Scopus]:7  IF:3.8/4.8 | Submit date:2022/08/02
Glucomannan  Polysaccharides  Self-adjuvant  Toll-like Receptors  Vaccination  
Serum amyloid A1 isoforms display different efficacy at Toll-like receptor 2 and formyl peptide receptor 2 Journal article
Chen M., Zhou H., Cheng N., Qian F., Ye R.D.. Serum amyloid A1 isoforms display different efficacy at Toll-like receptor 2 and formyl peptide receptor 2[J]. Immunobiology, 2014, 219(12), 916-923.
Authors:  Chen M.;  Zhou H.;  Cheng N.;  Qian F.;  Ye R.D.
Favorite | TC[WOS]:46 TC[Scopus]:47 | Submit date:2018/11/07
Formyl Peptide Receptors  Inflammation  Innate Immunity  Polymorphism  Serum Amyloid a  Toll-like Receptors